Skip to main content
. 2011 Feb 1;8(2):e1000411. doi: 10.1371/journal.pmed.1000411

Figure 1. Neglected disease drug registration timeline [7],[9],[11]–[19].

Figure 1

Additional source: correspondence with Novartis.